Pneumonia is one of the leading causes of mortality in intensive care units. Objectives: Pneumonia is one of the leading causes of death in the intensive care unit (ICU). Many biomarkers for predicted prognosis have been suggested; among these, procalcitonin (PCT) is known to increase in cases of bacterial infection. However, there have been many debates regarding whether PCT is an appropriate prognostic marker for pneumonia. Therefore, we investigated whether PCT can serve as a biomarker for pneumonia, and compared it with CURB-65, which is a known tool for predicting the prognosis of pneumonia. Methods: Levels of PCT and CURB-65 scores were compared between 30-day non-survival (n = 30) and survival (n = 101) patients. Relationships between PCT and CURB-65 were determined by using linear regression analysis, as well as by using receiver operating characteristic (ROC) curve analysis and calculation of the area under the curve (AUC). High and low PCT groups were compared. Results: High PCT and high CURB-65 score were positively associated with 30-day mortality. For the prediction of 30-day mortality, initial PCT and CURB-65 exhibited AUCs of 0.63 and 0.66; these were not significantly different (P = 0.132). We found that the high PCT group had a higher rate of initial treatment failure (91%, P = 0.004).
Pneumonia is one of the leading causes of mortality in intensive care units. 1 Community-acquired pneumonia (CAP) is associated with a mortality rate of approximately 20% for patients admitted to hospitals in the United Kingdom; nosocomial pneumonia has a higher mortality rate than CAP. 2, 3 Fast recognition of severe infections and prompt initiation of therapeutic regimens might decrease mortality. Empiric pathogen recognition and microbiologic pathogen recognition are likely to be helpful in choosing the appropriate antibiotics. 4 A growing number of clinical research studies have identified blood biomarkers that may reveal additional information regarding the prognosis of pa-tients with pneumonia. [5] [6] [7] [8] Procalcitonin (PCT) is a useful marker for the diagnosis of bacterial infection 9 ; this 116-amino-acid precursor is the prohormone of calcitonin, which is secreted by C-cells of the thyroid gland in response to hypercalcemia. Notably, it mirrors the severity of infection and has emerged as the most studied and promising blood marker for risk stratification of patients with pneumonia.
Concentrations of PCT tend to be higher in patients with pneumonia who exhibit more severe infections. 10, 11 Several risk scores, such as the pneumonia severity index (PSI) and the confusion, urea nitrogen, respiratory rate, blood pressure, age ≥ 65 years (CURB-65) score, can be used to assess the severity of pneumonia and predict mortality.
In particular, CURB-65 is a well-known set of criteria that is recommended by the British Thoracic
Society for the assessment of severity of pneumonia. It can also be a useful tool for estimating the prognosis of hospital-acquired pneumonia (HAP). 12 However, there have been many debates regarding whether PCT is an appropriate prognostic marker for pneumonia. Therefore, we investigated whether PCT can serve as a biomarker for patients with pneumonia requiring intensive care unit treatment, and compared it with CURB-65.
MATERIALS AND METHODS

Study Patients
We retrospectively conducted an observational 
RESULTS
Baseline characteristics
The baseline characteristics of study patients are summarized in vs. 77.9%, P = 0.025). The 30-day mortality in the present study was 22.9% (Table 1) .
CURB-65 and PCT as predictive factors of 30-day mortality
We performed univariate and multivariate anal-ysis by using risk factors for mortality (Table 2 ).
In the multivariate analysis, PCT (OR 1.020
(1.000-1.041), P = 0.047), and male sex (OR 3.073
(1.036-9.115), P = 0.043) were found to be in- PCT is related to initial treatment failure (Table   4 ). Subgroup analysis of the high PCT group showed an association with high CURB-65 ( ≥ 3) (Table 5 ). Initial mechanical ventilator use (P = 0.009), vasopressor use (P = 0.011) and leukopenia (P = 0.026) were related to initial treatment failure. However, low MDRD eGFR (P = 0.183), whether causative organism was identified (P = 0.094), and old age ( > 74) were not related to initial treatment failure.
DISCUSSION
A previous study has shown that PCT can be prognostic biomarker for CAP (AUC 0.60, CI:
0.52-0.67), but has a lower prognostic value than CURB-65 (P = 0.001). 17 One meta-analysis of the prognostic value of PCT in pneumonia 18 showed that elevated PCT level was associated with an increased risk of mortality (RR 4.18, 95% CI:
3.19-5.48). PCT is thus an emerging biomarker
for the diagnosis of bacterial infection. This study showed that high PCT level ( > 0.25 ng/dL) can be a risk factor for 30-day mortality.
We investigated the relationship of various characteristics to initial treatment failure. Leukopenia ( < 4000/µL) was related to treatment failure (P = 0.026), but old age ( > 75) and low eGFR were not. Low eGFR is known to indicate a risk of death with pneumonia, especially in young patients. 19 However, our study did not find similar evidence.
Initial mechanical ventilator use (P = 0.009), initial vasopressor use (P = 0.011), initial leukopenia (P = 0.026) were related to initial treatment failure.
Thus, we suspect that these patients have more severe pneumonia, so the risk of treatment failure is higher.
PCT is a known biomarker that is elevated in bacterial infections, especially in those caused by gram-negative bacteremia. 20 No research has indicated that high PCT is related to a high rate of causative organism identification. This study showed a minor tendency, but no significant difference; if the causative organism could be identified, the patient was not likely to show high PCT.
The CURB-65 score is frequently used to predict the prognosis of pneumonia, both in CAP and in HAP. Our investigation showed that initial PCT also has prognostic value, similar to that of CURB-65.
Our study has some limitations. First, it was performed at a single center, and a small number of patients were enrolled by using a retrospective design. In addition, we did not stratify cases of pneumonia on the basis of CAP or HAP.
Initial PCT can be a prognostic biomarker for mortality in severe pneumonia. Its value is similar to that of CURB-65 score.
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